Congenital Factor XIII Deficient Plasma

Factor XIII Deficient plasma is drawn from a human donor with a congenital deficiency.

• Human plasma from donor with congenital FXIII Deficiency
• Substrate quality
• <5% FXIII Activity by urea clot solubility
• No buffers or preservatives added

When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).

*George King Bio-Medical, Inc opened December 20, 1973. Due to this, the majority of our products fall in Preamendment Status